• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Malignancy Spectrum

    Malignancy Spectrum

    JournalISSN 2770-9140eISSN 2770-9140

    年发文量

    研究主题

    论文(79)

    排序
    1WU-KONG28: Sunvozertinib As a Potential Chemotherapy-Sparing First-Line Option for EGFR Exon 20 Insertion-Mutant Advanced NSCLC
    Runliang Ni, Yuwei Ding
    2026
    引用
    AI阅读
    加入学术空间
    2Dynamic Inflammatory Markers in Cervical Cancer: A New Prognostic Avenue or a Clinical Tool in Waiting?
    Haider Imran, Zahra Ali Haque, Muhammad Owais Mazhar, Zainab Jawad
    2026
    引用
    AI阅读
    加入学术空间
    3Myelodysplastic Syndrome Treatment Paradigm Comparisons: A Study of Japanese Real-World Health Claims Data
    Naoshi Obara, Yee Chang Soh,Hao Zhe Tay, Shi Hong Ooi, Tze Fang Maria Wong

    Background: Complex pathophysiology and high incidence of myelodysplastic syndromes (MDS) limits treatment options. Azacitidine (AZA) is the standard first-line (1L) treatment for high-risk MDS in Japan. This study evaluated treatment patterns and overall survival (OS) of patients with MDS in a real-world setting in Japan.Materials and methods: This non-interventional, retrospective study examined patients with MDS aged ≥ 18 years between April 2008 and September 2018. The primary outcome was the proportion of patients who received MDS-related treatment regimens as 1L in main cohort. Secondary outcomes included treatment patterns from 1L to third-line (3L) in main cohort and OS in 1L-AZA cohort (patients from main cohort who had AZA as 1L receiving 7-day or 5-day AZA dosing schedule).Results: Of 6,204 eligible patients, 1,068 comprised 1L-AZA cohort. Most patients received supportive therapies (53.2%) as 1L treatment, followed by antineoplastic agents (39.5%), with 31% receiving AZA. Approximately, 47% of patients switched to second-line (2L) treatment, while 25.3% advanced to 3L treatment. Patients in 1L-AZA cohort receiving 5-day AZA was associated with longer OS compared to 7-day AZA (median OS: 38.4 vs. 20.4 months; p < 0.001).Conclusion: The majority of Japanese patients with MDS received supportive therapies as 1L followed by AZA. Five-day AZA treatment significantly improved OS compared with 7-day AZA.

    2026
    引用
    AI阅读
    加入学术空间
    4Imaging Findings of a Rare Case of Pancreatic Schwannoma
    Vayun Garg, Suman Kumar

    Background: Pancreatic schwannomas (PS) are extraordinarily rare, benign neoplasms arising from the neural sheath of Schwann cells. Due to frequent degenerative changes such as cyst formation and calcification, they often mimic other pancreatic pathologies, making preoperative diagnosis difficult.Case Presentation: We report the case of a 64-year-old female presenting with chronic abdominal pain. Cross-sectional imaging revealed a large, peripherally enhancing cystic lesion with internal septations and calcification in the pancreatic head. Following Endoscopic Ultrasound (EUS), the patient developed secondary infection of the cyst with Klebsiella oxytoca, leading to a clinical and radiological mimicry of an infected pseudocyst. Percutaneous drainage was initially performed, followed by surgical enucleation. Histopathological analysis and S-100 protein positivity confirmed the diagnosis of a benign pancreatic schwannoma.Conclusion: This case highlights the diagnostic complexity of cystic pancreatic schwannomas, particularly when complicated by iatrogenic infection. Accurate differentiation from mucinous cystic neoplasms and pseudocysts is critical, as it allows for organ-sparing surgery (enucleation) rather than radical resection.

    2026
    引用
    AI阅读
    加入学术空间
    5Breast Cancer Screening and Socio-Demographic Factors in Kuwait: A Nationwide Study, 2014−2019
    Nourah M Alsheridah,Camille Maringe,Sara Benitez Majano, Hanaa Alkhawari,Bernard Rachet

    Background: Breast cancer (BC) incidence is increasing worldwide, including in Kuwait, which established a national BC screening program in 2014. This study examines overall BC screening uptake in Kuwait and its variation by socio-demographic characteristics. Material and methods: We conducted a cross-sectional study using 2014−2019 BC screening records from the Kuwait National Mammography Screening Program (KNMSP) and population data of the target female population (age 40−69). Ever-screened uptakes were calculated separately for Kuwaitis and non-Kuwaitis. The six regions were grouped into high and low population density, indirectly reflecting accessibility to screening centers. A complete-case approach was used for the analyses by socio-demographics characteristics. Screening and population counts were modeled using a generalized linear model with a negative binomial distribution, stratified by population density. Results: The BC ever-screened uptake remained very low, at 1.6% and 0.05% among Kuwaiti and non-Kuwaiti women, respectively. The complete-case analysis (using 88% of records) did not reveal strong variations by socio-demographic characteristics. Uptake was highest (3.4%) among Kuwaitis living in high-density regions, aged 40−49, ever married and with the highest education. In the same regions, this uptake decreased to 0.4% in Kuwaiti women aged 60−69, single and with the lowest education. Uptakes were even lower in low-density regions or non-Kuwaitis. Including mammogram tests performed outside the KNMSP had little impact on the overall findings.Discussion: Although socio-demographic and geographic factors were associated with differences in BC screening uptake, the proportion of screened women remained overall too low to have any public health impact at population level. This suggests that barriers extend beyond socio-demographic factors and may involve program awareness and accessibility.Conclusion: Major changes are needed in the KNMSP to reduce the burden of BC in Kuwait. Targeted interventions addressing awareness, accessibility, and cultural barriers are necessary to improve early detection and reduce BC mortality.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 79 篇论文

    高被引作者

    作者引用发文
    Zitong Zhao21
    Yongmei Song21
    Yazhu Zou21
    Xiaodong Jin11
    Shen Guosheng11
    Pengbo He11
    Yuehu Pu11
    WeiQiang Chen11
    Ting Zhao11
    Li Zhang11

    高产作者

    作者引用发文
    Shan Yu02
    Keechilat Pavithran02
    Mozaffar Aznab02
    Weicheng You12
    Kaifeng Pan12
    Xuemin Li02
    Hao Wang02
    Wesley M Jose02
    Wenqing Li12
    Guiquan Zhu12

    相关期刊

    暂无数据
    暂无数据